Genedrive (GDR) Stock Rating Reaffirmed by Peel Hunt

Genedrive (LON:GDR)‘s stock had its “buy” rating reissued by equities researchers at Peel Hunt in a note issued to investors on Thursday, ThisIsMoney.Co.Uk reports.

Shares of GDR opened at GBX 21 ($0.27) on Thursday. The stock has a market capitalization of $7.13 million and a PE ratio of -0.72. Genedrive has a 1 year low of GBX 18 ($0.24) and a 1 year high of GBX 39 ($0.51).

Genedrive Company Profile

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Further Reading: What is the Ex-Dividend Date in Investing?

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.